Advisor Group Holdings, Inc. Horizon Therapeutics Public LTD CO Transaction History

Advisor Group Holdings, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $960,204 - $1.12 Million	-9,701 Reduced 39.4%	14,920 $1.73 Million
Q2 2023 Aug 10, 2023	SELL	$96.34 - $112.38 $2.32 Million - $2.71 Million	-24,080 Reduced 49.44%	24,621 $2.53 Million
Q1 2023 May 12, 2023	SELL	$107.32 - $113.5 $1.81 Million - $1.91 Million	-16,861 Reduced 25.72%	48,701 $5.32 Million
Q4 2022 Feb 10, 2023	BUY	$62.39 - $113.8 $1.36 Million - $2.47 Million	21,725 Added 49.56%	65,562 $7.46 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $102,344 - $147,071	1,737 Added 4.13%	43,837 $2.71 Million
Q2 2022 Aug 10, 2022	BUY	$79.4 - $116.36 $883,166 - $1.29 Million	11,123 Added 35.91%	42,100 $3.36 Million
Q1 2022 May 04, 2022	SELL	$86.42 - $109.81 $288,902 - $367,094	-3,343 Reduced 9.74%	30,977 $3.07 Million
Q3 2021 Nov 05, 2021	BUY	$91.91 - $110.37 $83,178 - $99,884	905 Added 2.71%	34,320 $3.76 Million
Q2 2021 Aug 02, 2021	BUY	$86.24 - $95.92 $163,856 - $182,248	1,900 Added 6.03%	33,415 $3.14 Million
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $419,918 - $558,176	5,846 Added 22.77%	31,515 $2.9 Million
Q4 2020 Feb 10, 2021	SELL	$67.0 - $84.39 $1.45 Million - $1.83 Million	-21,697 Reduced 45.81%	25,669 $1.88 Million
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $774,269 - $1.12 Million	14,019 Added 42.04%	47,366 $3.68 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $60,158 - $113,504	1,992 Added 6.35%	33,347 $1.85 Million
Q1 2020 May 18, 2020	BUY	$24.87 - $38.56 $779,798 - $1.21 Million	31,355 New	31,355 $683,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.